Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Thierry Facon, Gordon Cook, Saad Z. Usmani et al. · Leukemia · 2022 · Randomised trial
Full textCC BY
Hematology
Filters3 filters applied
1 paperQuestions on this topic